These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 22207524)
1. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. Wang XF; Shi ZM; Wang XR; Cao L; Wang YY; Zhang JX; Yin Y; Luo H; Kang CS; Liu N; Jiang T; You YP J Cancer Res Clin Oncol; 2012 Apr; 138(4):573-84. PubMed ID: 22207524 [TBL] [Abstract][Full Text] [Related]
2. Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas. Tao T; Wang Y; Luo H; Yao L; Wang L; Wang J; Yan W; Zhang J; Wang H; Shi Y; Yin Y; Jiang T; Kang C; Liu N; You Y Eur J Cancer; 2013 Sep; 49(14):3055-63. PubMed ID: 23810250 [TBL] [Abstract][Full Text] [Related]
3. LINC01087 inhibits glioma cell proliferation and migration, and increases cell apoptosis via miR-384/Bcl-2 axis. Tian YH; Jia LW; Liu ZF; Chen YH Aging (Albany NY); 2021 Aug; 13(16):20808-20819. PubMed ID: 34459789 [TBL] [Abstract][Full Text] [Related]
4. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer. Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473 [TBL] [Abstract][Full Text] [Related]
5. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Shang C; Hong Y; Guo Y; Liu YH; Xue YX Med Sci Monit; 2014 Dec; 20():2571-7. PubMed ID: 25481483 [TBL] [Abstract][Full Text] [Related]
6. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587 [TBL] [Abstract][Full Text] [Related]
7. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Wang L; Shi ZM; Jiang CF; Liu X; Chen QD; Qian X; Li DM; Ge X; Wang XF; Liu LZ; You YP; Liu N; Jiang BH Oncotarget; 2014 Jul; 5(14):5416-27. PubMed ID: 24980823 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R. Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070 [TBL] [Abstract][Full Text] [Related]
9. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955 [TBL] [Abstract][Full Text] [Related]
10. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway. Zhao Y; Pang D; Wang C; Zhong S; Wang S Tumour Biol; 2016 Aug; 37(8):11485-93. PubMed ID: 27012554 [TBL] [Abstract][Full Text] [Related]
12. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108 [TBL] [Abstract][Full Text] [Related]
13. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1. Wang T; Zhang Y; Cui B; Wang M; Li Y; Gao K Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1394-1403. PubMed ID: 33200790 [TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
16. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells. Jin S; Li X; Dai Y; Li C; Wang D Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1. Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
19. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling. Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-106b suppresses the growth of human glioma cells. Zhang A; Hao J; Wang K; Huang Q; Yu K; Kang C; Wang G; Jia Z; Han L; Pu P J Neurooncol; 2013 Apr; 112(2):179-89. PubMed ID: 23377830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]